Karin Weissenborn Selected Research

symmetric dimethylarginine

12/2019	Markers of endothelial pathology to support detection of atrial fibrillation in embolic stroke of undetermined source.
1/2019	Plasma Dimethylarginine Levels and Carotid Intima-Media Thickness are related to Atrial Fibrillation in Patients with Embolic Stroke.
1/2018	ADAMTS-13 Activity Predicts Outcome in Acute Ischaemic Stroke Patients Undergoing Endovascular Treatment.
12/2017	Dimethylarginines in patients with intracerebral hemorrhage: association with outcome, hematoma enlargement, and edema.
11/2012	Asymmetric dimethyarginine as marker and mediator in ischemic stroke.
11/2012	Association of dimethylarginines and mediators of inflammation after acute ischemic stroke.
1/2011	High plasma dimethylarginine levels are associated with adverse clinical outcome after stroke.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Karin Weissenborn Research Topics

Disease

23	Ischemic Stroke 01/2022 - 12/2009
21	Stroke (Strokes) 01/2022 - 01/2008
15	Hepatic Encephalopathy 11/2019 - 02/2003
7	Infections 03/2020 - 09/2011
7	Cognitive Dysfunction 01/2020 - 11/2011
6	Inflammation (Inflammations) 01/2021 - 11/2012
5	Carotid Stenosis (Carotid Artery Stenosis) 01/2022 - 03/2016
5	Fatigue 01/2022 - 11/2004
5	Brain Injuries (Brain Injury) 01/2021 - 01/2011
4	Brain Diseases (Brain Disorder) 05/2022 - 11/2011
4	Atherosclerosis 01/2021 - 01/2011
4	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019 - 07/2010
4	Liver Diseases (Liver Disease) 01/2019 - 05/2009
4	Fibrosis (Cirrhosis) 07/2016 - 07/2004
3	Pathologic Constriction (Stenosis) 01/2022 - 10/2006
3	Thrombosis (Thrombus) 01/2022 - 01/2018
3	Atrial Fibrillation 04/2020 - 01/2019
3	Cerebral Hemorrhage 01/2020 - 06/2011
3	Hematoma 01/2020 - 12/2011
3	Seizures (Absence Seizure) 07/2012 - 09/2011
2	COVID-19 01/2021 - 01/2020
2	End Stage Liver Disease 01/2019 - 02/2003
2	Hyponatremia 01/2019 - 01/2014
2	Diabetes Mellitus 01/2019 - 01/2018
2	Hypertension (High Blood Pressure) 01/2018 - 05/2015
2	Neoplasms (Cancer) 09/2015 - 12/2009
2	Bacterial Infections (Bacterial Infection) 01/2014 - 09/2011
1	Ornithine Carbamoyltransferase Deficiency Disease 05/2022
1	Thromboinflammation 01/2022
1	Disease Progression 01/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Cerebral Infarction 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Atrial Remodeling 04/2020
1	Cytokine Release Syndrome 01/2020
1	Hemorrhage 01/2020
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2020
1	Embolic Stroke 01/2019

Drug/Important Bio-Agent (IBA)

8	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2019 - 01/2011
7	AmmoniaIBA 05/2022 - 02/2003
7	Biomarkers (Surrogate Marker)IBA 04/2020 - 01/2011
7	symmetric dimethylarginineIBA 12/2019 - 01/2011
6	Erythropoietin FDA Link 01/2021 - 12/2009
5	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2020 - 01/2008
5	Proteins (Proteins, Gene)FDA Link 01/2018 - 02/2003
4	CytokinesIBA 01/2022 - 01/2011
4	Arginine (L-Arginine)FDA Link 12/2019 - 01/2011
3	AutoantibodiesIBA 01/2021 - 05/2015
3	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2018 - 04/2012
3	C-Reactive ProteinIBA 01/2018 - 11/2012
3	Interleukin-6 (Interleukin 6)IBA 01/2018 - 11/2012
3	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2018 - 01/2012
3	Indicators and Reagents (Reagents)IBA 05/2015 - 01/2014
3	Nitric Oxide Synthase (NO Synthase)IBA 08/2013 - 01/2011
3	Glucose (Dextrose)FDA LinkGeneric 11/2011 - 06/2007
2	Complement System Proteins (Complement)IBA 01/2022 - 09/2011
2	Cell-Free Nucleic AcidsIBA 01/2022 - 01/2022
2	Deoxyribonucleases (DNase)FDA Link 01/2022 - 01/2022
2	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2021
2	Matrix Metalloproteinases (MMPs)IBA 01/2020 - 03/2013
2	dimethylarginineIBA 01/2019 - 01/2011
2	Inflammation MediatorsIBA 01/2018 - 11/2012
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017 - 06/2011
2	Lactulose (Duphalac)FDA LinkGeneric 07/2016 - 02/2003
2	BenzodiazepinesIBA 07/2016 - 01/2014
2	LithiumIBA 05/2015 - 04/2012
2	Pharmaceutical PreparationsIBA 03/2015 - 12/2009
2	NitrogenIBA 06/2013 - 05/2009
1	Ornithine Carbamoyltransferase (Ornithine Transcarbamylase)IBA 05/2022
1	VaccinesIBA 01/2022
1	Histones (Histone)IBA 01/2022
1	platelet-derived growth factor ABIBA 01/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	Peroxidase (Myeloperoxidase)IBA 01/2022
1	RevaceptIBA 01/2022
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2020
1	pro-brain natriuretic peptide (1-76)IBA 04/2020
1	methionyl-leucyl-phenylalanineIBA 03/2020
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2020
1	InflammasomesIBA 01/2020
1	Dabigatran FDA Link 01/2020
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2020
1	idarucizumabIBA 01/2020
1	CreatineIBA 01/2019
1	N-acetylaspartate (N-acetyl aspartate)IBA 01/2019
1	Choline (Choline Chloride)IBA 01/2019
1	Inositol (Myoinositol)IBA 01/2019
1	Phosphocreatine (Neoton)IBA 01/2019

Therapy/Procedure

12	Therapeutics 01/2022 - 02/2003
10	Liver Transplantation 11/2019 - 02/2003
4	Transplantation 01/2022 - 07/2011
3	Thrombectomy 01/2022 - 01/2021
3	Artificial Respiration (Mechanical Ventilation) 07/2012 - 09/2011
2	Length of Stay 01/2020 - 12/2011
2	Organ Transplantation 09/2015 - 07/2011
1	Treatment Delay 01/2021
1	Carotid Endarterectomy 01/2021
1	Kidney Transplantation 01/2020